2023-07-012024-12-312024-12-31false14152397DAISYFACE SKINCARE LTD2025-08-13falseiso4217:GBPxbrli:pure141523972023-06-30141523972024-12-31141523972023-07-012024-12-31141523972022-06-05141523972023-06-30141523972022-06-062023-06-3014152397bus:SmallEntities2023-07-012024-12-3114152397bus:AuditExempt-NoAccountantsReport2023-07-012024-12-3114152397bus:AbridgedAccounts2023-07-012024-12-3114152397bus:PrivateLimitedCompanyLtd2023-07-012024-12-3114152397core:WithinOneYear2024-12-3114152397core:AfterOneYear2024-12-3114152397core:WithinOneYear2023-06-3014152397core:AfterOneYear2023-06-3014152397core:ShareCapital2024-12-3114152397core:SharePremium2024-12-3114152397core:RevaluationReserve2024-12-3114152397core:OtherReservesSubtotal2024-12-3114152397core:RetainedEarningsAccumulatedLosses2024-12-3114152397core:ShareCapital2023-06-3014152397core:SharePremium2023-06-3014152397core:RevaluationReserve2023-06-3014152397core:OtherReservesSubtotal2023-06-3014152397core:RetainedEarningsAccumulatedLosses2023-06-3014152397core:LandBuildings2024-12-3114152397core:PlantMachinery2024-12-3114152397core:Vehicles2024-12-3114152397core:FurnitureFittings2024-12-3114152397core:OfficeEquipment2024-12-3114152397core:NetGoodwill2024-12-3114152397core:IntangibleAssetsOtherThanGoodwill2024-12-3114152397core:ListedExchangeTraded2024-12-3114152397core:UnlistedNon-exchangeTraded2024-12-3114152397core:LandBuildings2023-06-3014152397core:PlantMachinery2023-06-3014152397core:Vehicles2023-06-3014152397core:FurnitureFittings2023-06-3014152397core:OfficeEquipment2023-06-3014152397core:NetGoodwill2023-06-3014152397core:IntangibleAssetsOtherThanGoodwill2023-06-3014152397core:ListedExchangeTraded2023-06-3014152397core:UnlistedNon-exchangeTraded2023-06-3014152397core:LandBuildings2023-07-012024-12-3114152397core:PlantMachinery2023-07-012024-12-3114152397core:Vehicles2023-07-012024-12-3114152397core:FurnitureFittings2023-07-012024-12-3114152397core:OfficeEquipment2023-07-012024-12-3114152397core:NetGoodwill2023-07-012024-12-3114152397core:IntangibleAssetsOtherThanGoodwill2023-07-012024-12-3114152397core:ListedExchangeTraded2023-07-012024-12-3114152397core:UnlistedNon-exchangeTraded2023-07-012024-12-3114152397core:MoreThanFiveYears2023-07-012024-12-3114152397core:Non-currentFinancialInstruments2024-12-3114152397core:Non-currentFinancialInstruments2023-06-3014152397dpl:CostSales2023-07-012024-12-3114152397dpl:DistributionCosts2023-07-012024-12-3114152397core:LandBuildings2023-07-012024-12-3114152397core:PlantMachinery2023-07-012024-12-3114152397core:Vehicles2023-07-012024-12-3114152397core:FurnitureFittings2023-07-012024-12-3114152397core:OfficeEquipment2023-07-012024-12-3114152397dpl:AdministrativeExpenses2023-07-012024-12-3114152397core:NetGoodwill2023-07-012024-12-3114152397core:IntangibleAssetsOtherThanGoodwill2023-07-012024-12-3114152397dpl:GroupUndertakings2023-07-012024-12-3114152397dpl:ParticipatingInterests2023-07-012024-12-3114152397dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-12-3114152397core:ListedExchangeTraded2023-07-012024-12-3114152397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-12-3114152397core:UnlistedNon-exchangeTraded2023-07-012024-12-3114152397dpl:CostSales2022-06-062023-06-3014152397dpl:DistributionCosts2022-06-062023-06-3014152397core:LandBuildings2022-06-062023-06-3014152397core:PlantMachinery2022-06-062023-06-3014152397core:Vehicles2022-06-062023-06-3014152397core:FurnitureFittings2022-06-062023-06-3014152397core:OfficeEquipment2022-06-062023-06-3014152397dpl:AdministrativeExpenses2022-06-062023-06-3014152397core:NetGoodwill2022-06-062023-06-3014152397core:IntangibleAssetsOtherThanGoodwill2022-06-062023-06-3014152397dpl:GroupUndertakings2022-06-062023-06-3014152397dpl:ParticipatingInterests2022-06-062023-06-3014152397dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-062023-06-3014152397core:ListedExchangeTraded2022-06-062023-06-3014152397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-062023-06-3014152397core:UnlistedNon-exchangeTraded2022-06-062023-06-3014152397core:NetGoodwill2024-12-3114152397core:IntangibleAssetsOtherThanGoodwill2024-12-3114152397core:LandBuildings2024-12-3114152397core:PlantMachinery2024-12-3114152397core:Vehicles2024-12-3114152397core:FurnitureFittings2024-12-3114152397core:OfficeEquipment2024-12-3114152397core:AfterOneYear2024-12-3114152397core:WithinOneYear2024-12-3114152397core:ListedExchangeTraded2024-12-3114152397core:UnlistedNon-exchangeTraded2024-12-3114152397core:ShareCapital2024-12-3114152397core:SharePremium2024-12-3114152397core:RevaluationReserve2024-12-3114152397core:OtherReservesSubtotal2024-12-3114152397core:RetainedEarningsAccumulatedLosses2024-12-3114152397core:NetGoodwill2023-06-3014152397core:IntangibleAssetsOtherThanGoodwill2023-06-3014152397core:LandBuildings2023-06-3014152397core:PlantMachinery2023-06-3014152397core:Vehicles2023-06-3014152397core:FurnitureFittings2023-06-3014152397core:OfficeEquipment2023-06-3014152397core:AfterOneYear2023-06-3014152397core:WithinOneYear2023-06-3014152397core:ListedExchangeTraded2023-06-3014152397core:UnlistedNon-exchangeTraded2023-06-3014152397core:ShareCapital2023-06-3014152397core:SharePremium2023-06-3014152397core:RevaluationReserve2023-06-3014152397core:OtherReservesSubtotal2023-06-3014152397core:RetainedEarningsAccumulatedLosses2023-06-3014152397core:NetGoodwill2022-06-0514152397core:IntangibleAssetsOtherThanGoodwill2022-06-0514152397core:LandBuildings2022-06-0514152397core:PlantMachinery2022-06-0514152397core:Vehicles2022-06-0514152397core:FurnitureFittings2022-06-0514152397core:OfficeEquipment2022-06-0514152397core:AfterOneYear2022-06-0514152397core:WithinOneYear2022-06-0514152397core:ListedExchangeTraded2022-06-0514152397core:UnlistedNon-exchangeTraded2022-06-0514152397core:ShareCapital2022-06-0514152397core:SharePremium2022-06-0514152397core:RevaluationReserve2022-06-0514152397core:OtherReservesSubtotal2022-06-0514152397core:RetainedEarningsAccumulatedLosses2022-06-0514152397core:AfterOneYear2023-07-012024-12-3114152397core:WithinOneYear2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-12-3114152397core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3114152397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3114152397core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3014152397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3014152397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3014152397bus:Director12023-07-012024-12-3114152397bus:Director22023-07-012024-12-3114152397bus:Director32023-07-012024-12-31

DAISYFACE SKINCARE LTD

Registered Number
14152397
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

DAISYFACE SKINCARE LTD
Company Information
for the period from 1 July 2023 to 31 December 2024

Directors

Mark Hackner
Daisy Schaffer
Stephen Schaffer

Registered Address

Unit 3, Upp Hall Farm
Salmons Lane
Colchester
CO6 1RY

Registered Number

14152397 (England and Wales)
DAISYFACE SKINCARE LTD
Balance Sheet as at
31 December 2024

Notes

31 Dec 2024

30 Jun 2023

£

£

£

£

Fixed assets
Intangible assets3101,09859,367
Tangible assets468,192-
169,29059,367
Current assets
Stocks565,073-
Debtors610,1421,487
Cash at bank and on hand4,0571,230
79,2722,717
Creditors amounts falling due within one year7(52,784)(78,843)
Net current assets (liabilities)26,488(76,126)
Total assets less current liabilities195,778(16,759)
Net assets195,778(16,759)
Capital and reserves
Called up share capital136100
Share premium333,965-
Profit and loss account(138,323)(16,859)
Shareholders' funds195,778(16,759)
The financial statements were approved and authorised for issue by the Board of Directors on 13 August 2025, and are signed on its behalf by:
Stephen Schaffer
Director
Registered Company No. 14152397
DAISYFACE SKINCARE LTD
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover comprises the fair value of the consideration received or receivable for the sale of goods in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. The company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in the profit and loss account and is charged so as to write off the cost of assets, over their estimated useful lives, as follows: Development and design costs - straight line over 5 years Website costs - straight line over 5 years Trademarks - straight line over 10 years
Tangible fixed assets and depreciation
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses. The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation. Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Straight line (years)
Plant and machinery5
Office Equipment3
Stocks and work in progress
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognized immediately in profit or loss
Trade and other debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities. Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year31
3.Intangible assets

Total

£
Cost or valuation
At 01 July 2367,395
Additions82,372
Disposals(18,615)
At 31 December 24131,152
Amortisation and impairment
At 01 July 238,029
Charge for year22,025
At 31 December 2430,054
Net book value
At 31 December 24101,098
At 30 June 2359,367
4.Tangible fixed assets

Total

£
Cost or valuation
Additions86,996
At 31 December 2486,996
Depreciation and impairment
Charge for year18,804
At 31 December 2418,804
Net book value
At 31 December 2468,192
At 30 June 23-
5.Stocks

2024

2023

££
Other stocks65,073-
Total65,073-
6.Debtors: amounts due within one year

2024

2023

££
Other debtors9,2621,487
Prepayments and accrued income880-
Total10,1421,487
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables46,47312,615
Other creditors4,31165,229
Accrued liabilities and deferred income2,000999
Total52,78478,843
8.Share capital
The company has issued share capital of 13,550 ordinary shares of £0.01 each. The company had issued share capital of 100 ordinary shares of £1 each in the previous year. During the year the company sub-divided the 100 ordinary £1 shares into 10,000 £0.01 shares. The company then issued 3,550 new £0.01 shares at a premium.